Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01171729
What this trial is testing

Autologous Dendritic Cell Therapy for Hormone-Refractory Metastatic Prostate Cancer

Who this might be right for
Prostatic Cancer
Samsung Medical Center 12
Testing effectiveness (Phase 2)Ended earlyNCT00073970
What this trial is testing

Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy

Who this might be right for
Prostate Cancer
UNC Lineberger Comprehensive Cancer Center 37
Testing effectiveness (Phase 2)Study completedNCT00579423
What this trial is testing

Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate Cancer

Who this might be right for
ProstateCancer
Memorial Sloan Kettering Cancer Center 30
Early research (Phase 1)Study completedNCT00441337
What this trial is testing

MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies

Who this might be right for
Carcinoma, Non-Small-Cell LungColorectal CancerMalignant Melanoma+2 more
Bristol-Myers Squibb 39
Testing effectiveness (Phase 2)Study completedNCT00859729
What this trial is testing

Dose Finding Study of a DNA Vaccine Delivered With Intradermal Electroporation in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Uppsala University 15
Not applicableStudy completedNCT04063800
What this trial is testing

Prediction of the Risk of Biochemical Relapse After Radical Prostatectomy for Prostate Cancer Using Radomics on Pre-therapeutic MRI

Who this might be right for
Prostatic Adenocarcinoma
University Hospital, Brest 195
Testing effectiveness (Phase 2)Study completedNCT00203424
What this trial is testing

Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib

Who this might be right for
Prostate Cancer
Translational Oncology Research International 23
Early research (Phase 1)Ended earlyNCT00565227
What this trial is testing

Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.

Who this might be right for
Non-Small-Cell Lung CarcinomaProstate CancerBladder Cancer+1 more
University of Michigan Rogel Cancer Center 12
Early research (Phase 1)Study completedNCT01295632
What this trial is testing

Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049)

Who this might be right for
Advanced Cancer
Merck Sharp & Dohme LLC 65
Not applicableUnknownNCT05048537
What this trial is testing

18F-FACBC PET/CT and the PSA Kinetics for PCa Patients With Biochemical Recurrence.

Who this might be right for
Biochemical Relapse Fo Malignant Neoplasm of Prostate
National Taiwan University Hospital 20
Large-scale testing (Phase 3)Looking for participantsNCT07723248
What this trial is testing

Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
ORIC Pharmaceuticals 600
Not applicableUnknownNCT04870567
What this trial is testing

HDR Brachytherapy vs SABR in Early-intermediate Prostate Cancer

Who this might be right for
Biochemical Relapse Free SurvivalComplications Rates (Erectile Dysfunction, GI, GU Complications)
N.N. Petrov National Medical Research Center of Oncology 350
Testing effectiveness (Phase 2)Study completedNCT00348595
What this trial is testing

Study of 2 Different Doses of Revlimid in Biochemically Relapse Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 77
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Not applicableUnknownNCT05455736
What this trial is testing

STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence After prostatectomy-a Prospective Observational Study

Who this might be right for
Prostate CancerRelapse
Azienda Ospedaliero-Universitaria Careggi 90
Early research (Phase 1)Ended earlyNCT00512668
What this trial is testing

Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)UnknownNCT00405574
What this trial is testing

Study of ATN-224 in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Attenuon 50
Large-scale testing (Phase 3)Active Not RecruitingNCT01952223
What this trial is testing

A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse

Who this might be right for
Adenocarcinoma of ProstateProgression of Prostate Cancer
UNICANCER 761
Testing effectiveness (Phase 2)WithdrawnNCT00771017
What this trial is testing

Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Looking for participantsNCT06625970
What this trial is testing

Study Evaluating the Efficacy and Safety of Darolutamide and Stereotactic Dose Escalated Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of Relapse

Who this might be right for
High Risk Prostate CarcinomaProstate Cancer
UNICANCER 700
Next Page